University of Houston Apr 27 2026 University of Houston biologists have contributed to a potential breakthrough in treating Crohn's disease by shifting the clinical focus from symptom management to addressing a primary underlying cause of the condition. Crohn's disease, a chronic inflammatory bowel disease affecting approximately 1 million Americans, involves a cycle where the immune system attacks the epithelial lining, disrupting the "gut barrier." When this lining is damaged and fails to